| Quarter (USD) | Dec 23 | Dec 22 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 12 |
| Opened positions | 11 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 8.28 bn |
| Total shares | 17.28 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Lin Bioscience International | 17.10 mm | $0.00 |
| Armistice Capital | 148.00 k | $6.76 bn |
| STT State Street | 15.67 k | $715.85 mm |
| Point72 Asset Management | 7.31 k | $333.97 mm |
| Geode Capital Management | 6.70 k | $306.06 mm |
| HRT Financial | 5.41 k | $247.00 k |
| Virtus ETF Advisers | 1.81 k | $82.54 mm |
| MS Morgan Stanley | 1.04 k | $47.69 mm |
| GAMMA Investing | 428.00 | $19.55 mm |
| BAC Bank of America | 102.00 | $4.66 mm |
